Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Here’s What Happened

Shares of Anbio Biotechnology (NASDAQ:NNNN) gapped up before the market opened on Wednesday . The stock had previously closed at $24.61, but opened at $26.42. Anbio Biotechnology shares last traded at $27.0240, with a volume of 2,153 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Anbio Biotechnology Trading Up 0.5%

The firm has a 50-day moving average price of $23.79.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, December 30th. The company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $2.29 million for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.